Microbicides 2008 conference: From discovery to advocacy

<p>Abstract</p> <p>Recently revised statistics show the number of individuals living with HIV at over 33 million worldwide, with 68% being in sub-Saharan Africa. Current HIV prevention methods, such as condom use, monogamy and abstinence, are not always feasible. The need for impro...

Full description

Bibliographic Details
Main Authors: Tolley Elizabeth E, Mehendale Sanjay, Doncel Gustavo F, Ramjee Gita, Dickson Kim
Format: Article
Language:English
Published: BMC 2008-08-01
Series:AIDS Research and Therapy
Online Access:http://www.aidsrestherapy.com/content/5/1/19
id doaj-eb60cae4a9354fd4ac542d62b0dc1a03
record_format Article
spelling doaj-eb60cae4a9354fd4ac542d62b0dc1a032020-11-25T00:25:07ZengBMCAIDS Research and Therapy1742-64052008-08-01511910.1186/1742-6405-5-19Microbicides 2008 conference: From discovery to advocacyTolley Elizabeth EMehendale SanjayDoncel Gustavo FRamjee GitaDickson Kim<p>Abstract</p> <p>Recently revised statistics show the number of individuals living with HIV at over 33 million worldwide, with 68% being in sub-Saharan Africa. Current HIV prevention methods, such as condom use, monogamy and abstinence, are not always feasible. The need for improved HIV preventative technologies remains urgent. Of these, microbicides represent a promising female-initiated preventative method. Microbicides are designed to be applied vaginally to prevent HIV and STI acquisition. Research is also being undertaken to assess the safety of the product during rectal application.</p> <p>The biannual Microbicides conference took place in New Delhi, India from 24–27 February 2008. The conference was open to delegates from the scientific and medical fields, as well as communities and advocates. In addition to microbicide research and development, the conference afforded the opportunity for the discussion of key issues such as ethics, acceptability, access, and community involvement.</p> <p>In this conference report we provide brief summaries of recent advancements made and challenges experienced in microbicide research and development, including updates on basic and clinical science, social and behavioural science, and community mobilisation and advocacy activities pertaining to clinical trials.</p> http://www.aidsrestherapy.com/content/5/1/19
collection DOAJ
language English
format Article
sources DOAJ
author Tolley Elizabeth E
Mehendale Sanjay
Doncel Gustavo F
Ramjee Gita
Dickson Kim
spellingShingle Tolley Elizabeth E
Mehendale Sanjay
Doncel Gustavo F
Ramjee Gita
Dickson Kim
Microbicides 2008 conference: From discovery to advocacy
AIDS Research and Therapy
author_facet Tolley Elizabeth E
Mehendale Sanjay
Doncel Gustavo F
Ramjee Gita
Dickson Kim
author_sort Tolley Elizabeth E
title Microbicides 2008 conference: From discovery to advocacy
title_short Microbicides 2008 conference: From discovery to advocacy
title_full Microbicides 2008 conference: From discovery to advocacy
title_fullStr Microbicides 2008 conference: From discovery to advocacy
title_full_unstemmed Microbicides 2008 conference: From discovery to advocacy
title_sort microbicides 2008 conference: from discovery to advocacy
publisher BMC
series AIDS Research and Therapy
issn 1742-6405
publishDate 2008-08-01
description <p>Abstract</p> <p>Recently revised statistics show the number of individuals living with HIV at over 33 million worldwide, with 68% being in sub-Saharan Africa. Current HIV prevention methods, such as condom use, monogamy and abstinence, are not always feasible. The need for improved HIV preventative technologies remains urgent. Of these, microbicides represent a promising female-initiated preventative method. Microbicides are designed to be applied vaginally to prevent HIV and STI acquisition. Research is also being undertaken to assess the safety of the product during rectal application.</p> <p>The biannual Microbicides conference took place in New Delhi, India from 24–27 February 2008. The conference was open to delegates from the scientific and medical fields, as well as communities and advocates. In addition to microbicide research and development, the conference afforded the opportunity for the discussion of key issues such as ethics, acceptability, access, and community involvement.</p> <p>In this conference report we provide brief summaries of recent advancements made and challenges experienced in microbicide research and development, including updates on basic and clinical science, social and behavioural science, and community mobilisation and advocacy activities pertaining to clinical trials.</p>
url http://www.aidsrestherapy.com/content/5/1/19
work_keys_str_mv AT tolleyelizabethe microbicides2008conferencefromdiscoverytoadvocacy
AT mehendalesanjay microbicides2008conferencefromdiscoverytoadvocacy
AT doncelgustavof microbicides2008conferencefromdiscoverytoadvocacy
AT ramjeegita microbicides2008conferencefromdiscoverytoadvocacy
AT dicksonkim microbicides2008conferencefromdiscoverytoadvocacy
_version_ 1725350029478068224